| Literature DB >> 23296390 |
Abstract
2012 has witnessed new developments in targeted therapies for osteoarthritis, and in ways to identify those patients who might benefit most from their application. Together, these advances could go some way to addressing the urgent need for disease-modifying treatments for this common disease.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23296390 DOI: 10.1038/nrrheum.2012.225
Source DB: PubMed Journal: Nat Rev Rheumatol ISSN: 1759-4790 Impact factor: 20.543